StemRIM is a bio company that aims to develop "regeneration-inducing medicines".
Stem Rim is a biotechnology company aiming to develop “regenerative medicine”.We are developing drugs based on a new mechanism of action that mobilizes stem cells present in the living body to the injured or diseased tissue without removing them out of the body and induces functional tissue regeneration.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 9, 2019 | IPO | — | — | — | — | Detail |
Dec 28, 2018 | Series Unknown | ¥745.02M | 6 | — | — | Detail |
Dec 7, 2018 | Series Unknown | ¥699.93M | 1 | DCI Partners | — | Detail |
Dec 15, 2017 | Series Unknown | ¥199.98M | 1 | Mitsubishi UFJ Capital | — | Detail |
Nov 17, 2017 | Series Unknown | ¥1B | 10 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
DCI Partners | Yes | Series Unknown |
Mitsubishi UFJ Capital | Yes | Series Unknown |
Shionogi | Yes | Corporate Round |
M3i | — | Series Unknown |
KSP | — | Series Unknown |
Kyogin Lease & Capital | — | Series Unknown |
M3 | — | Series Unknown |
Miyako Capital | — | Series Unknown |
SMBC Venture Capital | — | Series Unknown |
Mizuho Capital | — | Series Unknown |